|
1
|
Luo Y, Akhatayeva Z, Mao C, Jiang F, Guo Z, Xu H, Lan X. The ovine HIAT1 gene: mRNA expression, InDel mutations, and growth trait associations. Front Vet Sci 2023; 10:1134903. [PMID: 37138914 PMCID: PMC10149746 DOI: 10.3389/fvets.2023.1134903] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/31/2022] [Accepted: 03/27/2023] [Indexed: 05/05/2023] Open
Abstract
Background The hippocampal abundant transcript 1 (HIAT1) gene, also known as major facilitator superfamily domain-containing 14A (MFSD14A), encodes for a transmembrane transporter protein and has been previously shown to be associated with milk production in buffalo and sheep breeds, as well as growth traits in chicken and goats. However, tissue level distribution of the ovine HIAT1 gene, as well as its effect on body morphometric traits in sheep, has yet to be studied. Methods The HIAT1 mRNA expression profile of Lanzhou fat-tailed (LFT) sheep was determined by quantitative real-time PCR (qPCR). A total of 1498 sheep of three indigenous Chinese sheep breeds were PCR-genotyped for polymorphisms of HIAT1 gene. Student's t-test was used to observe the association between the genotype and sheep morphometric traits. Results HIAT1 was widely expressed in all examined tissues, and was particularly abundant in the testis of male LFT sheep. Additionally, a 9-bp insertion mutation (rs1089950828) located within the 5'-upstream region of HIAT1 was investigated in Luxi black-headed (LXBH) sheep and Guiqian semi-fine wool (GSFW) sheep. The wildtype allele frequency 'D' was found to be more prevalent than that of the mutant allele 'I'. Furthermore, low genetic diversity was confirmed in all sampled sheep populations. Subsequent association analyses indicated an association between the 9-bp InDel mutation of interest and the morphometric traits of LXBH and GSFW sheep. Furthermore, yearling ewes with a heterozygous genotype (ID) demonstrated smaller body sizes, while yearling rams and adult ewes with the heterozygous genotype were found to have overall better growth performance. Conclusion These findings imply that functional InDel polymorphism (rs1089950828) has the potential to be utilized for marker-assisted selection (MAS) of growth traits in domestic Chinese sheep populations.
Collapse
Affiliation(s)
- Yunyun Luo
- Key Laboratory of Animal Genetics, Breeding and Reproduction of Shaanxi Province, College Animal Science and Technology, Northwest A&F University, Yangling, Shaanxi, China
| | - Zhanerke Akhatayeva
- Key Laboratory of Animal Genetics, Breeding and Reproduction of Shaanxi Province, College Animal Science and Technology, Northwest A&F University, Yangling, Shaanxi, China
| | - Cui Mao
- Key Laboratory of Animal Genetics, Breeding and Reproduction of Shaanxi Province, College Animal Science and Technology, Northwest A&F University, Yangling, Shaanxi, China
- Shandong Key Lab of Animal Disease Control and Breeding, Institute of Animal Science and Veterinary Medicine, Shandong Academy of Agricultural Sciences, Jinan, China
| | - Fugui Jiang
- Shandong Key Lab of Animal Disease Control and Breeding, Institute of Animal Science and Veterinary Medicine, Shandong Academy of Agricultural Sciences, Jinan, China
| | - Zhengang Guo
- Bijie Animal Husbandry and Veterinary Science Research Institute, Bijie, China
| | - Hongwei Xu
- College of Life Science and Engineering, Northwest Minzu University, Lanzhou, China
- *Correspondence: Hongwei Xu
| | - Xianyong Lan
- Key Laboratory of Animal Genetics, Breeding and Reproduction of Shaanxi Province, College Animal Science and Technology, Northwest A&F University, Yangling, Shaanxi, China
- Xianyong Lan
| |
Collapse
|
|
2
|
Kang SG, Lee SE, Choi MJ, Chang JY, Kim JT, Zhang BY, Kang YE, Lee JH, Yi HS, Shong M. Th2 Cytokines Increase the Expression of Fibroblast Growth Factor 21 in the Liver. Cells 2021; 10:cells10061298. [PMID: 34073755 PMCID: PMC8225035 DOI: 10.3390/cells10061298] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/16/2021] [Revised: 05/17/2021] [Accepted: 05/20/2021] [Indexed: 12/28/2022] Open
Abstract
Interleukin-4 (IL-4) and IL-13 are the major T helper 2 (Th2) cytokines, and they are involved in the regulation of metabolism in the adipose tissue. The liver contains diverse innate and adaptive immune cells, but it remains to be determined whether Th2 cytokines modulate energy metabolism in the liver. Here, using gene expression data from the Gene Expression Omnibus (GEO) and the BXD mouse reference population, we determined that the Th2 cytokines IL-4 and IL-13 increase the secretion of fibroblast growth factor 21 (FGF21) in the liver. In vitro experiments confirmed that FGF21 was highly expressed in response to IL-4 and IL-13, and this response was abolished by the Janus kinase (JAK)-signal transducer and activator of transcription 6 (STAT6) blockade. Moreover, FGF21 expression in response to Th2 cytokines was augmented by selective peroxisome proliferator-activated receptor α (PPARα) inhibition. In vivo administration of IL-4 increased FGF21 protein levels in the liver in a STAT6-dependent manner, but FGF21 secretion in response to IL-4 was not observed in the epididymal white adipose tissue (eWAT) despite the activation of STAT6. Intraperitoneal administration of IL-33, an activator of type 2 immune responses, significantly increased the level of FGF21 in the serum and liver after 24 h, but repeated administration of IL-33 attenuated this effect. Taken together, these data demonstrate that the IL-4/IL-13–STAT6 axis regulates metabolic homeostasis through the induction of FGF21 in the liver.
Collapse
Affiliation(s)
- Seul-Gi Kang
- Research Center for Endocrine and Metabolic Diseases, School of Medicine, Chungnam National University, 282 Munhwaro, Daejeon 35015, Korea; (S.-G.K.); (S.-E.L.); (M.-J.C.); (J.-Y.C.); (J.-T.K.); (B.-Y.Z.); (Y.-E.K.); (J.-H.L.)
- Department of Medical Science, School of Medicine, Chungnam National University, 266 Munhwaro, Daejeon 35015, Korea
| | - Seong-Eun Lee
- Research Center for Endocrine and Metabolic Diseases, School of Medicine, Chungnam National University, 282 Munhwaro, Daejeon 35015, Korea; (S.-G.K.); (S.-E.L.); (M.-J.C.); (J.-Y.C.); (J.-T.K.); (B.-Y.Z.); (Y.-E.K.); (J.-H.L.)
- Department of Medical Science, School of Medicine, Chungnam National University, 266 Munhwaro, Daejeon 35015, Korea
| | - Min-Jeong Choi
- Research Center for Endocrine and Metabolic Diseases, School of Medicine, Chungnam National University, 282 Munhwaro, Daejeon 35015, Korea; (S.-G.K.); (S.-E.L.); (M.-J.C.); (J.-Y.C.); (J.-T.K.); (B.-Y.Z.); (Y.-E.K.); (J.-H.L.)
- Department of Medical Science, School of Medicine, Chungnam National University, 266 Munhwaro, Daejeon 35015, Korea
| | - Joon-Young Chang
- Research Center for Endocrine and Metabolic Diseases, School of Medicine, Chungnam National University, 282 Munhwaro, Daejeon 35015, Korea; (S.-G.K.); (S.-E.L.); (M.-J.C.); (J.-Y.C.); (J.-T.K.); (B.-Y.Z.); (Y.-E.K.); (J.-H.L.)
- Department of Medical Science, School of Medicine, Chungnam National University, 266 Munhwaro, Daejeon 35015, Korea
| | - Jung-Tae Kim
- Research Center for Endocrine and Metabolic Diseases, School of Medicine, Chungnam National University, 282 Munhwaro, Daejeon 35015, Korea; (S.-G.K.); (S.-E.L.); (M.-J.C.); (J.-Y.C.); (J.-T.K.); (B.-Y.Z.); (Y.-E.K.); (J.-H.L.)
- Department of Medical Science, School of Medicine, Chungnam National University, 266 Munhwaro, Daejeon 35015, Korea
| | - Ben-Yuan Zhang
- Research Center for Endocrine and Metabolic Diseases, School of Medicine, Chungnam National University, 282 Munhwaro, Daejeon 35015, Korea; (S.-G.K.); (S.-E.L.); (M.-J.C.); (J.-Y.C.); (J.-T.K.); (B.-Y.Z.); (Y.-E.K.); (J.-H.L.)
- Department of Medical Science, School of Medicine, Chungnam National University, 266 Munhwaro, Daejeon 35015, Korea
| | - Yea-Eun Kang
- Research Center for Endocrine and Metabolic Diseases, School of Medicine, Chungnam National University, 282 Munhwaro, Daejeon 35015, Korea; (S.-G.K.); (S.-E.L.); (M.-J.C.); (J.-Y.C.); (J.-T.K.); (B.-Y.Z.); (Y.-E.K.); (J.-H.L.)
- Department of Medical Science, School of Medicine, Chungnam National University, 266 Munhwaro, Daejeon 35015, Korea
| | - Ju-Hee Lee
- Research Center for Endocrine and Metabolic Diseases, School of Medicine, Chungnam National University, 282 Munhwaro, Daejeon 35015, Korea; (S.-G.K.); (S.-E.L.); (M.-J.C.); (J.-Y.C.); (J.-T.K.); (B.-Y.Z.); (Y.-E.K.); (J.-H.L.)
- Department of Medical Science, School of Medicine, Chungnam National University, 266 Munhwaro, Daejeon 35015, Korea
| | - Hyon-Seung Yi
- Research Center for Endocrine and Metabolic Diseases, School of Medicine, Chungnam National University, 282 Munhwaro, Daejeon 35015, Korea; (S.-G.K.); (S.-E.L.); (M.-J.C.); (J.-Y.C.); (J.-T.K.); (B.-Y.Z.); (Y.-E.K.); (J.-H.L.)
- Department of Medical Science, School of Medicine, Chungnam National University, 266 Munhwaro, Daejeon 35015, Korea
- Translational Immunology Institute, Chungnam National University, 266 Munhwaro, Daejeon 35015, Korea
- Correspondence: (H.-S.Y.); (M.S.)
| | - Minho Shong
- Research Center for Endocrine and Metabolic Diseases, School of Medicine, Chungnam National University, 282 Munhwaro, Daejeon 35015, Korea; (S.-G.K.); (S.-E.L.); (M.-J.C.); (J.-Y.C.); (J.-T.K.); (B.-Y.Z.); (Y.-E.K.); (J.-H.L.)
- Department of Medical Science, School of Medicine, Chungnam National University, 266 Munhwaro, Daejeon 35015, Korea
- Correspondence: (H.-S.Y.); (M.S.)
| |
Collapse
|